Figure 1.

(A) Computed tomography (CT) scan of a patient with symptoms of carcinoid syndrome despite treatment with a high-dose long-acting octreotide. Demonstrated are multiple bilateral liver metastases including a dominant lesion bridging the right and left lobes. (B) Selective hepatic angiogram delineating the arterial supply to the hypervascular liver metastases. (C) Immediate follow-up hepatic angiogram postchemoembolization (Mitomycin/Adriamycin/Cisplatin mixed with Ethiodol). (D) Three-month follow-up CT shows mixed areas of Ethiodol uptake, necrosis, and hypervascularity. Of clinical importance, the patient's octreotide dose had been gradually tapered off and symptoms were well controlled at follow-up.